Carmichael Hill & Associates, Inc. - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Carmichael Hill & Associates, Inc. ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$183
-13.7%
200.0%0.00%
Q2 2023$212
-13.5%
200.0%0.00%
Q1 2023$245
-1.2%
200.0%0.00%
Q4 2022$248200.0%0.00%
Q3 2022$0200.0%0.00%
Q2 2022$0200.0%0.00%
Q1 2022$0200.0%0.00%
Q4 2021$0200.0%0.00%
Q3 2021$0200.0%0.00%
Q2 2021$0
-100.0%
200.0%0.00%
-100.0%
Q1 2021$1,000200.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders